-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LM6b867oTxwIRMzx/+7h70kOpv7GwX0QG2uUThNmAM3ryooOAR1GIGF+zzhnFqGV FiMOkGBrBeDTtFoitTWTGw== 0001181431-06-006405.txt : 20060130 0001181431-06-006405.hdr.sgml : 20060130 20060130151156 ACCESSION NUMBER: 0001181431-06-006405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060126 FILED AS OF DATE: 20060130 DATE AS OF CHANGE: 20060130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEIER THOMAS E CENTRAL INDEX KEY: 0001188556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09623 FILM NUMBER: 06561578 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVAX CORP CENTRAL INDEX KEY: 0000772197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161003559 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 3055756000 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: IVAX CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IVACO INDUSTRIES INC DATE OF NAME CHANGE: 19871213 FORMER COMPANY: FORMER CONFORMED NAME: INLAND VACUUM INDUSTRIES INC DATE OF NAME CHANGE: 19870611 4 1 rrd105005.xml FORM 4 X0202 4 2006-01-26 0 0000772197 IVAX CORP IVX 0001188556 BEIER THOMAS E 4400 BISCAYNE BLVD MIAMI FL 33137-3227 0 1 0 0 Senior Vice President and CFO Common Stock, $.10 Par Value Per Share 2006-01-26 4 D 0 87891 D 0 I Trust Common Stock, $.10 Par Value Per Share 2006-01-26 4 D 0 3974 D 0 I ESPP Common Stock, $.10 Par Value Per Share 2006-01-26 4 D 0 702 D 0 I IRA Employee Stock Option (Right to Buy) 11.70 2006-01-26 4 D 0 35156 0 D 2010-01-12 Common Stock 35156 0 D Employee Stock Option (Right to Buy) 20.79 2006-01-26 4 D 0 31250 0 D 2011-01-21 Common Stock 31250 0 D Employee Stock Option (Right to Buy) 15.43 2006-01-26 4 D 0 25000 0 D 2012-01-21 Common Stock 25000 0 D Employee Stock Option (Right to Buy) 8.79 2006-01-26 4 D 0 50000 0 D 2013-03-05 Common Stock 50000 0 D Employee Stock Option (Right to Buy) 18.40 2006-01-26 4 D 0 15000 0 D 2014-03-14 Common Stock 15000 0 D Employee Stock Option (Right to Buy) 18.40 2006-01-26 4 D 0 50000 0 D 2014-03-14 Common Stock 50000 0 D Employee Stock Option (Right to Buy) 15.93 2006-01-26 4 D 0 10000 0 D 2010-02-22 Common Stock 10000 0 D Held by the Thomas E. Beier and Evelyn M. Beier Trustee FBO Thomas E. Beier Trust. Disposed of pursuant to merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 37,226 shares of Teva Common Stock, having a market value of $40.63 per share on the effective date of the merger and cash in the amount of $1,142,583 subject to pro-ration. Held in the IVAX Employee Stock Purchase Plan. Disposed of pursuant to merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 1,683 shares of Teva Common Stock, having a market value of $40.63 per share on the effective date of the merger and cash in the amount of $51,662 subject to pro-ration. Held in a Self Employment Retirement Plan. Disposed of pursuant to merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 297 shares of Teva Common Stock, having a market value of $40.63 per share on the effective date of the merger and cash in the amount of $9,126 subject to pro-ration. This option, which provided for vesting in four equal annual installments beginning January 13, 2000, was assumed by Teva in the merger and replaced with an option to purchase 29,780 shares of Teva Common Stock for $13.81 per share. This option, which provided for vesting in four equal annual installments beginning January 22, 2001, was assumed by Teva in the merger and replaced with an option to purchase 26,471 shares of Teva Common Stock for $24.54 per share. This option, which provided for vesting in four equal annual installments beginning January 22, 2002, was assumed by Teva in the merger and replaced with an option to purchase 21,177 shares of Teva Common Stock for 18.22 per share. This option, which provided for vesting in four equal annual installments beginning March 6, 2003, was assumed by Teva in the merger and replaced with an option to purchase 42,355 shares of Teva Common Stock for $10.38 per share. This option, which provided for vesting in four equal annual installments beginning March 15, 2004, was assumed by Teva in the merger and replaced with an option to purchase 12,706 shares of Teva Common Stock for $21.72 per share. This option, which provided for vesting in four equal annual installments beginning March 15, 2004, was assumed by Teva in the merger and replaced with an option to purchase 42,355 shares of Teva Common Stock for $21.72 per share. This option, which provided for vesting in four equal annual installments beginning February 23, 2005, was assumed by Teva in the merger and replaced with an option to purchase 8,471 shares of Teva Common Stock for $18.81 per share. /s/ Thomas E. Beier 2006-01-26 -----END PRIVACY-ENHANCED MESSAGE-----